Glenview Capital Management’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-8,603,438
Closed -$817M 60
2018
Q3
$817M Buy
8,603,438
+1,623,869
+23% +$138M 5.19% 1
2018
Q2
$539M Buy
6,979,569
+2,337,583
+50% +$175M 3.68% 10
2018
Q1
$321M Buy
+4,641,986
New +$354M 1.88% 22
2016
Q4
Sell
-640,960
Closed -$45.2M 54
2016
Q3
$45.2M Buy
640,960
+568,838
+789% +$42.5M 0.32% 44
2016
Q2
$5.47M Buy
+72,122
New +$5.3M 0.04% 46

Other funds holding ESRX

Glenview Capital Management's ESRX Position: Q4 2018 in Review

Glenview Capital Management sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 8,603,438 shares — an estimated $817M sold.

Glenview Capital Management first reported a position in ESRX in Q2 2016 and held it in 5 quarters. The position peaked at $817M in Q3 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Glenview Capital Management reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Glenview Capital Management sold 8,603,438 Express Scripts Holding Company shares in Q4 2018, an estimated $817M.
  • Glenview Capital Management first reported a position in Express Scripts Holding Company in Q2 2016 and held it in 5 quarters.
  • Glenview Capital Management's Express Scripts Holding Company position peaked at $817M in Q3 2018.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Glenview Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.